Corpus ID: 29380896

Measurement of 5-FU plasma levels in patients with advanced cancer: correct approach to practical procedures is essential.

@article{Blaschke2011MeasurementO5,
  title={Measurement of 5-FU plasma levels in patients with advanced cancer: correct approach to practical procedures is essential.},
  author={Martina Blaschke and S. Cameron and Kathy Emami and Jutta Blumberg and Ulrike Wegner and Martin Nischwitz and Giuliano Ramadori},
  journal={International journal of clinical pharmacology and therapeutics},
  year={2011},
  volume={49 1},
  pages={
          83-5
        }
}

Topics from this paper

5-Fluorouracil Response Prediction and Blood Level-guided Therapy in Oncology: Existing Evidence Fundamentally Supports Instigation.
TLDR
The UH2/U ratio is outlined as a parameter for 5-FU response/toxicity prediction and highlights key studies emphasizing the value of5-FU TDM. Expand
Feasibility of 5-fluorouracil pharmacokinetic monitoring using the My-5FU PCM™ system in a quaternary oncology centre
TLDR
Therapeutic 5FU drug monitoring was feasible using commercial kits and analysers and hence warrants development as a routine standard of care in cancer patients and the variability in the 5FU exposure parameters is consistent with other studies using the My 5FU PCM kit. Expand
Transforming Growth Factor-β1 messenger Ribonucleic Acid Expression in Porcine Thyroid Follicles in vitro by Growth Factors, Iodine, or δ-Iodolactone.; Thyroid 1997; 7: 633-40
4. Matyakhina L, Bei TA, McWhinney SR, Pasini B, Cameron S, Gunawan B, Stergiopoulos SG, Boikos S, Muchow M, Dutra A, Pak E, Campo E, Cid MC, Gomez F, Gaillard RC, Assie G, Füzesi L, Baysal BE, EngExpand
Evaluation of the performance of elastomeric pumps in practice: are we under-delivering on chemotherapy treatments?
TLDR
The performance of pumps varied, which affected nurse workload and patients’ waiting-times, and a smart system is an option to monitor theperformance of pumps and to predict their accuracy. Expand
Individualização Farmacocinética das Doses de 5-Fluoruracil no Câncer Colorretal Pharmacokinetic Individualization of 5-Fluorouracil Doses in Colorectal Cancer Individualización Farmacocinética de las Dosis de 5-Fluorouracil en el Cáncer Colorrectal
TLDR
Métodos analíticos baseados em cromatografia líquida de alta eficiência estão disponíveis para determinar 5-Fu em plasma de forma confiável, permitindo a disseminação do monitoramento terapêutico desse fármaco. Expand
Gender-specific elimination of continuous-infusional 5-fluorouracil in patients with gastrointestinal malignancies: results from a prospective population pharmacokinetic study
TLDR
Gender-specific elimination of 5FU is supported by the present data and may partly explain the gender-specific association between DPYD risk variants and 5FU-specific toxicity. Expand
Measurements of 5-FU Plasma Concentrations in Patients with Gastrointestinal Cancer: 5-FU Levels Reflect the 5-FU Dose Applied
TLDR
With critical analysis of the measurements and correct performance of blood sampling, the measurement of 5-FU plasma concentrations with the immunoassay may in the future allow to optimize 4-FU dosing and to identify the cause of toxicity. Expand
Variability in fluorouracil exposure during continuous intravenous infusion.
TLDR
This poster presents a meta-analyses of the immune systems of eight canine coronavirus coronas and shows clear patterns in response to vaccination and also investigates the role of immune checkpoints in the development of these immune systems. Expand
cancer 5-FU schedules , serum 5-FU levels and their relationship to therapy response and toxicity in patients with gastrointestinal cancer
Correspondence to Dr. Silke Cameron, MD Department of Gastroenterology and Endocrinology, University Medical Center Göttingen, Robert-Koch-Straße 40, 37075 Göttingen, Germany silke.cameron@med.Expand